longevity

UK Biobank study links social gap to biomarker shifts

A UK Biobank analysis of 20,048 adults found biomarker scores worsened faster with lower education and money worries, and predicted later death and heart disease

Laboratory bench with research samples

eClinicalMedicine published a UK Biobank analysis on 29 September 2026 looking at whether short-term change in a composite biomarker score sits on the pathway between social disadvantage and death or disease. The researchers analysed 20,048 participants, 10,266 women and 9,782 men, aged 37 to 73 at baseline, all of whom had repeated biomarker measurements taken a mean of 4.3 years apart. Their Biological Health Score was derived from 15 biomarkers covering the cardiovascular, metabolic, inflammatory, liver and renal systems. Outcomes were tracked through registry linkage until December 2022. Total score increased over the interval in both men and women, and every sub-score rose except the cardiovascular one. Lower education, low qualification level and financial difficulties were each associated with greater increases in the score. The work was funded by the Research Council of Norway and the European Commission.

What the numbers showed

A 1-unit increase in score change was associated with higher all-cause mortality in men, at a hazard ratio of 1.46 (95% CI 1.25 to 1.71), and in women, at 1.26 (1.02 to 1.56). For atherosclerotic cardiovascular disease the figures were 1.33 (1.13 to 1.57) in men and 1.24 (1.03 to 1.48) in women, and for cancer incidence 1.16 (1.01 to 1.41) in men and 1.29 (1.06 to 1.58) in women. The mediation analysis was more limited. The authors report no clear mediation by score change for women, for cardiovascular disease or for cancer, and a small but statistically significant mediated proportion only for the link between low income or financial difficulties and mortality in men.

What this means for you

This is an observational cohort study, and the authors acknowledge the limitations of their dataset. The authors also note a healthy-volunteer bias in UK Biobank, amplified among those who came back for a second assessment. The study tested neither a diet nor a supplement nor any other intervention. What it measured is that a set of routine blood and clinical markers drifted upward over roughly four years, that the drift was patterned by education and money, and that the size of the drift carried information about later mortality and cardiovascular disease beyond a single baseline reading. The authors' own conclusion is that repeated measurements may add information to one-off testing, and that longer series of measurements are the next step.

How Perqen members save

Perqen membership costs £4.99 a month or £29.99 a year, and member pricing applies across the whole 1,393-product catalogue of supplements from established brands.

This article reports published news and research and is for information only. Food supplements are not a substitute for a varied diet or medical care, and no product mentioned is intended to diagnose, treat, cure or prevent any disease. Speak to your GP or pharmacist before changing what you take, especially if you are pregnant, breastfeeding, or taking prescribed medicines.

Sources